Sputnik V COVID Vaccine expected to available at Delhi’s Indraprastha Apollo Hospital from next week

The Russian COVID-19 vaccine Sputnik V is expected to be available at Indraprastha Apollo Hospital in Delhi from June 15, sources said.

According to the sources, the program for Sputnik V rollout at Indraprastha Apollo Hospital will depend on the Consignment received. The first phase of the Sputnik V rollout by Apollo Hospitals and Dr Reddy’s Laboratories had started on a pilot basis on May 17 in Hyderabad and on May 18 in Vishakhapatnam. Besides Apollo Hospitals. The vaccine is also available in Hyderabad at Continental Hospitals.


The price per dose of Sputnik V at private hospitals as per the pricing schedule issued by the central government has been capped at Rs 1,145. The Russian Direct Investment (RDIF), earlier on June 10 announced that the efficacy of the Sputnik V COVID-19 vaccine during a vaccination campaign by Bahrain’s Ministry of Health was estimated to be at 94.3 per cent.

Recently, The DCGI has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis with a certain condition, official sources said.

The Pune-based firm has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar the Sputnik COVID-19 vaccine in India for examination, test, and analysis at its licensed Hadapsar facility with certain conditions,” an official source said.

The company had submitted an application to the DGCI in this regard. According to the four conditions set by the DCGI, the Serum Institute will have to submit a copy of the agreement between it and the Gamaleya Research Institute of Epidemiology and Microbiology for transfer of cell bank and virus stock and submit the copy of the agreement for technology transfer with Gamaleya, the source said.